These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 16706756)
1. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial. Badran AY; Ali AU; Gomaa AS Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959 [TBL] [Abstract][Full Text] [Related]
3. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial. Leenutaphong V; Nettakul A; Rattanasuwon P J Med Assoc Thai; 1999 Sep; 82(9):868-75. PubMed ID: 10561942 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma. Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872 [TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women. Handog EB; Galang DA; de Leon-Godinez MA; Chan GP Int J Dermatol; 2009 Aug; 48(8):896-901. PubMed ID: 19659873 [TBL] [Abstract][Full Text] [Related]
7. Topical 10% zinc sulfate solution for treatment of melasma. Sharquie KE; Al-Mashhadani SA; Salman HA Dermatol Surg; 2008 Oct; 34(10):1346-9. PubMed ID: 18616534 [TBL] [Abstract][Full Text] [Related]
8. Skin-lightening effects of a new face care product in patients with melasma. Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815 [TBL] [Abstract][Full Text] [Related]
9. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma. Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992 [TBL] [Abstract][Full Text] [Related]
10. A pilot study using reflectance confocal microscopy (RCM) in the assessment of a novel formulation for the treatment of melasma. Tsilika K; Levy JL; Kang HY; Duteil L; Khemis A; Hughes R; Passeron T; Ortonne JP; Bahadoran P J Drugs Dermatol; 2011 Nov; 10(11):1260-4. PubMed ID: 22052305 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study. Sharma R; Mahajan VK; Mehta KS; Chauhan PS; Rawat R; Shiny TN Clin Exp Dermatol; 2017 Oct; 42(7):728-734. PubMed ID: 28649780 [TBL] [Abstract][Full Text] [Related]
12. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study. Soliman MM; Ramadan SA; Bassiouny DA; Abdelmalek M J Cosmet Dermatol; 2007 Jun; 6(2):89-94. PubMed ID: 17524124 [TBL] [Abstract][Full Text] [Related]
13. Oral tranexamic acid lightens refractory melasma. Tan AWM; Sen P; Chua SH; Goh BK Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008 [TBL] [Abstract][Full Text] [Related]
14. Oral tranexamic acid for the treatment of melasma. Karn D; Kc S; Amatya A; Razouria EA; Timalsina M Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051 [TBL] [Abstract][Full Text] [Related]
15. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma. Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359 [TBL] [Abstract][Full Text] [Related]
16. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels. Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA Dermatol Surg; 2006 Dec; 32(12):1429-36. PubMed ID: 17199649 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma. Suh KS; Sung JY; Roh HJ; Jeon YS; Kim YC; Kim ST J Dermatolog Treat; 2011 Aug; 22(4):233-8. PubMed ID: 20443754 [TBL] [Abstract][Full Text] [Related]
18. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser. Cho HH; Choi M; Cho S; Lee JH J Dermatolog Treat; 2013 Aug; 24(4):292-6. PubMed ID: 22103770 [TBL] [Abstract][Full Text] [Related]
19. Assessment of combined fractional CO Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171 [TBL] [Abstract][Full Text] [Related]
20. Different therapeutic modalities for treatment of melasma. Azzam OA; Leheta TM; Nagui NA; Shaarawy E; Hay RM; Hilal RF J Cosmet Dermatol; 2009 Dec; 8(4):275-81. PubMed ID: 19958431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]